IPW
ADPT icon

Impact Partnership Wealth’s Adaptive Biotechnologies ADPT Stock Holding History

Impact Partnership Wealth’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,078
Closed -$114K – 263
2024
Q4 		$114K Buy
19,078
+1,539
+9% +$8.48K 0.02% 281
2024
Q3 		$89.8K Buy
17,539
+385
+2% +$1.68K 0.02% 234
2024
Q2 		$62.1K Buy
+17,154
New +$54.4K 0.02% 213

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Impact Partnership Wealth's ADPT Position: Q1 2025 in Review

Impact Partnership Wealth sold out of Adaptive Biotechnologies (ADPT) in Q1 2025, closing a stake of 19,078 shares — an estimated $114K sold.

Impact Partnership Wealth first reported a position in ADPT in Q2 2024 and held it in 3 quarters. The position peaked at $114K in Q4 2024. 225 funds tracked by Wall St. Rank hold ADPT as of Q1 2025.

  • Impact Partnership Wealth reported no remaining Adaptive Biotechnologies position as of Q1 2025 after selling out during the quarter.
  • Impact Partnership Wealth sold 19,078 Adaptive Biotechnologies shares in Q1 2025, an estimated $114K.
  • Impact Partnership Wealth first reported a position in Adaptive Biotechnologies in Q2 2024 and held it in 3 quarters.
  • Impact Partnership Wealth's Adaptive Biotechnologies position peaked at $114K in Q4 2024.
  • 225 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2025.

Based on Impact Partnership Wealth's 13F filing for Q1 2025, filed 5 May 2025.